has been cited by the following article(s):
[1]
|
Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices
Journal of Hypertension,
2023
DOI:10.1097/HJH.0000000000003538
|
|
|
[2]
|
Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices
Journal of Hypertension,
2023
DOI:10.1097/HJH.0000000000003538
|
|
|
[3]
|
Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices
Journal of Hypertension,
2023
DOI:10.1097/HJH.0000000000003538
|
|
|
[4]
|
Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report
Diabetology International,
2021
DOI:10.1007/s13340-021-00500-x
|
|
|